The Global Small Molecule Drug Discovery Market (2023 to 2027) - Projected CAGR of 9.5% During the Forecast Period

DUBLIN, June 29, 2023 /PRNewswire/ -- The "Small Molecule Drug Discovery Global Market Report 2023" report has been added to  ResearchAndMarkets.com's offering.

The global small molecule drug discovery market is expected to grow from $52.14 billion in 2022 to $57.51 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%.

The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe.

The small molecule drug discovery market is expected to reach $82.56 billion in 2027 at a CAGR of 9.5%.

Technological innovations are the key trend gaining popularity in the small molecule drug discovery market. Major companies operating in the small molecule drug discovery market are focusing on developing new products.

For instance, in January 2023, Dotmatics, a US-based provider of digital science platform, launched Small Molecule Drug Discovery Solution. It is uniquely designed with integrated scientific R&D platform that has pre-configured workflows and expanded data management capabilities. It reduces the operational inefficiencies, and speeds the process of taking data from insights to decisions.

In July 2022, GSK Plc., a UK-based pharmaceutical and biotechnology company, acquired Sierra Oncology Inc. (Sierra Oncology) for a deal of 1.9 billion dollars. This acquisition broadens GSK's advanced cancer portfolio, highlighting its dedication to enhancing patient outcomes and maximizing shareholder value. Also, Sierra is expected to help GSK establish a sustainable process of innovative therapeutics by utilizing modalities like small molecules, antibodies, antibody-drug conjugates, and cell therapy. Sierra Oncology Inc. is a US-based clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.

The rising incidence of chronic diseases is expected to boost the growth of the small molecule drug discovery market going forward. Chronic diseases refer to conditions that last for a year or longer, hinder everyday activities, demand continuous medical care, or both. Small-molecule medications can be used to treat chronic conditions like HIV, cancer, infections, heart disease, and renal disease, and these medications are generally more economical for patients with chronic conditions. Hence, the rising incidence of chronic diseases is expected to boost the small molecule drug discovery market.

For instance, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2023, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the rising incidence of chronic diseases is driving the growth of the small molecule drug discovery market.

The small molecule drug discovery market consists of sales of diphenhydramine, aspirin, and other "medicine cabinet" drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

North America was the largest region in the small molecule drug discovery market in 2022. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in small molecule drug discovery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the small molecule drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Key Topics Covered:

Small Molecule Drug Discovery Market Characteristics

Small Molecule Drug Discovery Market Trends And Strategies

Small Molecule Drug Discovery Market - Macro Economic Scenario

• COVID-19 Impact On Small Molecule Drug Discovery Market
• Ukraine-Russia War Impact On Small Molecule Drug Discovery Market
• Impact Of High Inflation On Small Molecule Drug Discovery Market

Small Molecule Drug Discovery Market Size And Growth

• Global Small Molecule Drug Discovery Historic Market, 2017-2022, $ Billion
• Global Small Molecule Drug Discovery Forecast Market, 2022-2027F, 2032F, $ Billion

Small Molecule Drug Discovery Market Segmentation

• Global Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Small Molecule Drugs
• Biologic Drugs

• Global Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• High Throughput Screening
• Pharmacogenomics
• Combinatorial Chemistry
• Nanotechnology
• Other Technologies

• Global Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Oncology
• Central Nervous System
• Cardiovascular
• Respiratory
• Metabolic Disorders
• Gastrointestinal
• Other Therapeutic Areas

• Global Small Molecule Drug Discovery Market, Segmentation By Process Or Phase, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Target ID Or Validation
• Hit Generation And Selection
• Lead Identification
• Lead Optimization

• Global Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Pharmaceutical Companies
• Contract Research Organizations
• Other End Users

Small Molecule Drug Discovery Market Regional And Country Analysis

• Global Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Global Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Asia-Pacific Small Molecule Drug Discovery Market

• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• Asia-Pacific Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Asia-Pacific Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles

• Pfizer Inc.
• GlaxoSmithKline plc
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Johnson & Johnson
• Gilead Sciences Inc.
• Merck KGaA
• Novartis AG
• 21st Century Therapeutics Inc.
• 4SC AG
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• Immunocure Inc.
• Labcorp Drug Development

Key Mergers And Acquisitions In The Small Molecule Drug Discovery Market

Small Molecule Drug Discovery Market Future Outlook and Potential Analysis

For more information about this report visit https://www.researchandmarkets.com/r/pipoo9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets